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Abstract
Background Acute kidney injury (AKI) significantly increases morbidity and mortality for hospitalized children, yet 
sociodemographic risk factors for pediatric AKI are poorly described. We examined sociodemographic differences in pediatric 
AKI amongst a national cohort of hospitalized children.
Methods Secondary analysis of the most recent (2012) Kids’ Inpatient Database (KID) from the Agency for Healthcare Research 
and Quality. Study sample weights were used to obtain national estimates of AKI (defined by administrative data). KID is a 
nationally representative sample of pediatric discharges throughout the USA. Linear risk regression models were used to assess 
the relationship between our primary exposures (race/ethnicity, health insurance, household urbanization, gender, and age) and 
the diagnosis of AKI, adjusting for comorbidities.
Results A total of 1,699,841 hospitalizations met our study criteria. In 2012, AKI occurred in approximately 12.3/1000 pediatric 
hospitalizations, which translates to almost 30,000 children nationally. Asian/Pacific Islander, African-American, and Hispanic 
children were at slightly increased risk for AKI compared to Caucasian children (adjusted risk difference (RD) 4.5 per 1000 
hospitalizations, 95% confidence interval (CI) 2.9–6.0; 2.5/1000 hospitalizations, 95% CI 1.7–3.3; and 1.7/1000 hospitalizations, 
95% CI 0.9–2.5, respectively). Uninsured children were more likely to suffer AKI compared to children with any health 
insurance (e.g., no insurance versus Medicaid: adjusted RD 14.4/1000 hospitalizations, 95% CI 12.7–16.2). Based on these 
national estimates, one episode of AKI might be prevented if 70 (95% CI 62–79) hospitalized children without insurance were 
provided with Medicaid.
Conclusions Pediatric AKI occurs more frequently in racial minority and uninsured children, factors linked to lower socioeco-
nomic status.
Keywords Acute kidney injury . Child . Risk factors .
Medicaid . Health services research
Introduction
Acute kidney injury (AKI) can be fatal if untreated, but, unlike
chronic kidney disease (CKD), an AKI episode is usually
reversible, assuming timely and accurate diagnosis and treat-
ment. AKI, historically termed “acute renal failure,” is defined
as an acute injury or sudden decrease in kidney function,
which is currently diagnosed by changes in serum creatinine
within 48 h to 7 days or oliguria for 6 h or more. Clinical
factors associated with the development of AKI amongst hos-
pitalized children include systemic illnesses, exposure to
nephrotoxic medications, invasive procedures, and iodinated
contrast [1].
Pediatric AKI is estimated to occur in approximately 5% of
all hospitalized children and up to 25% of all critically ill
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children [2, 3]. AKI results in high rates of short-term morbid-
ity and mortality as well as increased hospital costs and length
of stay [4, 5]. Moreover, up to 50–60% of patients may have
long-term sequelae such as CKD or hypertension [6].
Knowing which subsets of patients or parameters indicate
the greatest risk for AKI is paramount to instituting healthcare
guidelines and policies aimed at decreasing these high rates.
Few studies have evaluated sociodemographic risk factors
for AKI in pediatric populations. Those that have done so tend
to focus on subsets of the pediatric population. One retrospec-
tive study in post-operative congenital cardiac surgery patients
found that age less than 12 months was a risk factor for AKI
[7]. Another study found that nephrotic children who were
non-Caucasian were at higher risk of AKI than Caucasian
children [8]. None have looked at race or other broad
sociodemographic risk factors for AKI in a large, diverse pe-
diatric population, yet we know from adult studies that those
of minority populations or lower socioeconomic status have
worse kidney outcomes [9–11].
We sought to determine if there are disparities in the inci-
dence of AKI according to sociodemographic factors amongst
a national pediatric cohort within the Hospital Care and
Utilization Program (HCUP) Kids’ Inpatient Database (KID)
[12]. HCUP KID provides detailed information on a national-
ly representative sample of pediatric inpatients. In high-
income countries, over 99% of pediatric AKI is diagnosed in
the inpatient setting [13].
Methods
Design
This study is a secondary analysis of the most recent release
(2012) of KID data to assess for sociodemographic differences
in the diagnosis of pediatric AKI (age 1–20 years). We used
weighted sampling methods to obtain national estimates.
Data source
The KID, developed by the Agency for Healthcare Research
and Quality’s HCUP, is the largest nationally representative
sample of pediatric hospitalizations from > 4100 community
hospitals (defined as short-term, general and specialty
hospitals, excluding rehabilitation facilities) throughout the
USA. The database includes discharge summary-level data
only (i.e., limited demographics, ICD-9 billing codes, hospital
outcome) and some limited data on hospital characteristics.
Each unit of observation is a hospitalization, so it is possible
for individuals to be included twice if they had two separate
hospitalizations in 2012. However, AKI is also recurrent, and
an individual is at risk for AKI with each hospitalization. For
2012, 44 states were included; not included were Alabama,
Delaware, District of Columbia, Idaho, Maine, Mississippi,
and New Hampshire.
Inclusion/exclusion criteria
All admitted children in the KID aged 1–20 years on admis-
sion were included. The database only provides age in years
(not months or days). Therefore, children < 1 year of age were
not included due to their potential different etiologies of AKI
and higher likelihood of AKI coding errors due to the diffi-
culty with AKI recognition. The kidneys in infants < 1 year
are also still maturing and reaching their maximal functional
potential. Patients were excluded if they had ICD-9 codes for
renal transplants (v42.0), end-stage renal disease/chronic dial-
ysis (585.6, 585.5, 792.5, v45.1, v45.11, v45.12, v56.0-v56.2,
v56.31, v56.32, v56.8), or if they were missing data on pri-
mary diagnosis.
Outcome
AKI was a binary outcome and could occur at any point dur-
ing the hospitalization. AKI was defined by ICD-9 codes
(584.5–584.9, acute renal failure; 586, renal failure unspeci-
fied; 580.0, 580.4, 580.8, 580.9, acute glomerulonephritis;
593.9, acute renal disease; 866, injury to kidney with unspec-
ified injury; 958.5, renal failure following crushing; 997.5,
renal failure due to a medical procedure).
Exposures
Race/ethnicity was self-reported and categorized as
Caucasian, African-American, Hispanic, Asian or Pacific
Islander, Native American, and Other. Health insurance status
was categorized as Private, Medicaid, Other, or No insurance.
Household urbanization was defined in six categories (“cen-
tral” metropolitan counties with ≥ 1 million population,
“fringe” metropolitan counties with ≥ 1 million population,
metropolitan counties with 250,000–999,999 population, met-
ropolitan counties with 50,000–249,999 population, micro-
politan counties (urban cluster population 10,000-49,999), or
rural counties). Gender was dichotomous as either male or
female. Age was continuous in years.
Covariates
In addition to the above sociodemographic factors, we felt that
a child’s comorbidities may be a strong confounder in
assessing some of the relationships. Comorbidities were de-
fined by HCUP through the chronic condition indicator tool
[14]. The tool was developed to facilitate health services re-
search and readily determine if a patient has a chronic condi-
tion according to administrative data. The tool uses an ad-
vanced algorithm, originally reported by Hwang et al. [15],
to classify all ICD-9 codes into chronic or not chronic condi-
tions. Examples of included chronic conditions that may in-
fluence AKI are cancer, congenital heart disease, chronic kid-
ney disease, cystic fibrosis, diabetes mellitus, diabetes
insipidus, and inflammatory bowel disease. Prematurity is
not included, and we attempted to evaluate prematurity as a
separate comorbidity, but we felt the variable to be too inac-
curate. Only 21 hospitalizations had this as a diagnosis code
amongst the 1,699,841 eligible hospitalizations.
Analysis
Descriptive statistics were calculated for patient demo-
graphics, hospital characteristics, and hospital region stratified
by racial/ethnic differences as our primary exposure of inter-
est. HCUP provides weights to allow for national estimates
based on post-stratification of hospital ownership, bed size,
teaching status, urbanization of hospital location, region, and
status as a freestanding children’s hospital. Further informa-
tion about the KID sampling design and procedures can be
found at: http://www.hcup-us.ahrq.gov/kidoverview.org [12].
Given the large sample size and method of data collection,
we were able to accurately determine the risk of AKI in this
population. Hence, to give a broader understanding of the
public health impact of our results, we present risk differences
(RD) as our contrast estimate of choice, rather than relative
risks or odds ratios that can be inflated depending on the true
proportion affected. Therefore, linear risk regression models
with binomial distributions were used to assess the relation-
ship between our primary sociodemographic exposures and
the diagnosis of AKI.
A useful tool to evaluate important confounders in a poten-
tial exposure-outcome relationship is a causal diagram, or a
Directed Acyclic Graph (DAG). It allows visualization of your
primary exposure (e.g., race) and outcome (e.g., AKI) in rela-
tionship to all other potential variables. It helps ensure there
are not mediators or colliders included in adjustment analyses
which could introduce bias. We provide simplified descrip-
tions of key variables as DAGs can get quite complicated;
for example, confounders can be hidden on indirect pathways.
More in-depth descriptions and explanations of causal dia-
grams can be found in this overview in CJASN [16] or in the
epidemiological literature [17, 18]. A confounder by defini-
tion is a variable that potentially impacts the primary exposure
and the outcome, and visually is displayed on a DAG as a
variable with an arrow pointing towards both the exposure
and the outcome. A mediator on the other hand has an arrow
coming from exposure (into mediator) and then pointing to-
wards the outcome.Modifiers cannot be directly visualized on
DAGs. A DAG was drawn for our exposures and outcome
(Fig. 1). Depending on the relationship assessed, we evaluated
potential confounders of comorbidities and the other expo-
sures based on the DAG and substantive knowledge from
the literature to more explicitly evaluate each individual
exposure-outcome relationship. Both traditional methods of
model adjustment and stratification were used to control for
potential confounders in our analyses.
All statistical analyses were conducted in SAS, version 9.4
(SAS Institute, Inc., Cary, NC). The institutional review board
at the University of North Carolina at Chapel Hill reviewed
this secondary data analysis of de-identified data and classi-
fied this as non-human subjects research status.
Sensitivity analyses
Roughly 8% of patients in the KID were missing data on
race/ethnicity. We conducted a sensitivity analysis using mul-
tiple imputation to correct for missing race/ethnicity. The im-
putation model included all covariates listed in the Covariates
section. Acute glomerulonephritis codes (580.x) are not typi-
cally included in AKI analyses, yet we felt given the inaccu-
racies with coding this may be an important group that is
otherwise missed. We conducted a sensitivity analysis remov-
ing all acute glomerulonephritis codes.
Results
Patient characteristics
The KID contained 3,195,782 hospitalizations in 2012,
and 1,699,841 of these met our study cohort criteria.
The majority excluded were due to age < 1 year.
Applying the HCUP weights to this subset translates to
about 2.4 million hospitalizations for 2012 across the
USA. The majority of patients were Caucasian (46.3%),
followed by Hispanics and African-Americans (Table 1).
Most children were female across race/ethnicities. The
majority of hospitalizations occurred in large, urban
teaching hospitals. While only a minority of children hos-
pitalized did not have health insurance (4.3%), this ex-
trapolates to over 100,000 children nationally. Lack of
insurance differed by race/ethnicity, ranging from 3.7–
5.5% (Table 1). Also, more Caucasian and Asian/Pacific
Islander children had private insurance, while Medicaid
was carried by more African-American, Hispanic, and
Native American children (Table 1). These overall demo-
graphics are similar to those of US children in 2012 [19,
20]. A sensitivity analysis removing the ICD codes asso-
ciated with acute glomerulonephritis revealed no differ-
ences in our results.
Approximately 30,000 children aged 1–20 years were di-
agnosed with AKI while hospitalized (Table 1). The crude risk
of an AKI episode for a pediatric hospitalization in 2012 was
1.2% or 12.3 cases per 1000 pediatric hospitalizations.
Race/ethnicity differences
Crude risk of AKI was highest amongst Asian/Pacific Islander
children (14.9 cases/1000 pediatric hospitalizations) and low-
est amongst Hispanic children (10.0 cases/1000 hospitaliza-
tions) (Table 2). When adjusted for comorbidities, insurance
status, gender, age, and household urbanization, disparities by
race/ethnicity were attenuated (Table 3). However, AKI risks
amongst African-American (RD 2.5 cases/1000 hospitaliza-
tions, 95% confidence interval (CI) 1.7–3.3), Hispanic (RD
1.7 cases/1000 hospitalizations, 95% CI 0.9–2.5), and Asian/
Pacific Islander children (RD 4.5 cases/1000 hospitalizations,
95% CI 2.9–6.0) remained elevated compared to Caucasian
children. Crude analyses indicated that having chronic comor-
bidities were a significant risk factor for AKI, and the risk
increased with increasing number of chronic illnesses
(Fig. 2). Adjusting for comorbidities alone greatly attenuated
the racial disparities seen with AKI risks (Fig. 2). We conduct-
ed a sensitivity analysis using multiple imputation to correct
for the 8% missing race/ethnicity and found no meaningful
differences in our results.
Health insurance status
Lack of health insurance was the sociodemographic risk factor
most strongly associated with AKI in hospitalized children
(Table 2). The uninsured population had nearly double the
crude risk of AKI compared to all pediatric inpatients (23.1
cases/1000 hospitalizations amongst the uninsured versus
12.3 cases/1000 hospitalizations overall). The absolute risk
difference for those without insurance versus Medicaid was
14.4/1000 hospitalizations.
After adjusting for chronic illnesses, Medicaid remained a
protective factor against AKI even when stratified further by
race and gender (Fig. 2). Model including chronic illnesses
and race yielded similar results (Table 3). We conducted a
sensitivity analysis excluding 19- and 20-year-old patients as
these patients may have different access to health insurance
(i.e., typically not able to access Medicaid as easily as those
≤18 years old) and in our population almost half of those
without insurance were 19–20 years of age (47.1%)
(Supplementary Table 1). Interestingly, the risk of AKI
remained higher for those without insurance versus
Medicaid but it was greatly attenuated (RD 4.4, 95% CI
2.8–5.9) in this sensitivity analysis, controlling for race/
ethnicity and comorbidities.
Household urbanization
Our one neighborhood-level factor (household urbanization)
was not a significant risk factor for AKI. Only fringe vs central
metropolitan counties with ≥ 1 million population had a risk
difference of 0.9 per 1000 hospitalizations (95% CI 0–1.9)
with p value 0.05 (Table 2).
Gender
Compared to female patients, males were associated with a
higher risk of AKI (RD 8.2/1000 hospitalizations, 95% CI 7.6–
8.8) (Table 2), and this difference persisted after adjustment for
chronic conditions (Fig. 3). This increased riskwas present for all
Caucasian, African-American, and Hispanic boys, regardless of
insurance strata (Fig. 3). The risk remained after modeling con-














Fig. 1 A simplified directed acyclic graph of the potential relationships
between sociodemographic factors and acute kidney injury. Primary
exposures: race, health insurance status (insurance), household
urbanization, gender, and age. Primary outcome: acute kidney injury
(AKI). Confounders are variables that have an arrow going towards
exposure and towards outcome (directly or indirectly). Examples would
be genetic history between Race and AKI (indirectly via comorbidities).
Mediators are variables along the causal pathway (arrow coming from
exposure and then arrow going towards outcome). Example would be
Hospital characteristics as a mediator between Insurance and AKI.
Mediators are variables not typically controlled for in multivariate
modeling as they can then introduce bias
urbanization (RD 7.3, 95% CI 6.7–7.9) but was again attenuated
with sensitivity analysis removing 19- and 20-year-olds (RD 3.1,
95% CI 2.6–3.6; Supplementary Table 1).
Age
Older age was associated with a higher risk of AKI diagnosis
(Table 2). To evaluate the trend further, we evaluated smaller
subsets of children and compared risk differences in similar
combinations of multivariate analyses as presented in Table 3.
Those aged 15–16 years of age had similar risk difference as-
sociations to those presented in Supplementary Table 1 (all
children excluding those 19- and 20-year-olds). The risk differ-
ences continue to diverge as we evaluated 17–18-year-olds and
then 19–20-year-olds; the 19–20-year-olds who are uninsured
have a risk of 20 more episodes of AKI per 1000 hospitaliza-
tions (RD 20.1, 95% CI 17.7–22.6) compared to 19–20-year-
olds with Medicaid, adjusting for race and chronic illnesses.








n = 2,392,031 n = 1,107,114 n = 431,738 n = 488,040 n = 50,553 n = 22,232 n = 112,779
Gender (female)b, col % 59.1 58.0 60.9 61.8 53.9 62.5 57.3
Agec, median (IQR) 14 (6, 18) 15 (6, 18) 15 (6, 18) 14 (5, 18) 11 (3, 17) 15 (5, 18) 13 (4, 18)
Prevalence of CKD, col % 0.3 0.3 0.4 0.3 0.4 0.2 0.3
Number of chronic illnessesd, median (IQR) 0.5 (0, 1.8) 0.6 (0, 1.9) 0.6 (0, 1.7) 0.1 (0, 1.3) 0.5 (0, 1.7) 0.3 (0, 1.5) 0.4 (0, 1.7)
Type/location of hospital, col %
Rural 9.3 12.7 5.7 4.1 5.1 23.6 4.8
Urban, non-teaching 24.6 25.6 21.2 30.6 20.0 22.0 22.9
Urban, teaching 66.1 61.7 73.1 65.4 74.9 54.4 72.3
Size of hospitale, col %
Small 10.6 10.7 9.2 9.5 7.7 15.4 11.4
Medium 23.5 24.2 23.9 24.1 29.0 18.1 20.6
Large 65.9 65.1 66.9 66.3 63.4 66.5 68.0
Location in the USA, col %
New England 3.5 4.4 2.4 3.5 4.2 0.4 4.0
Middle Atlantic 14.1 13.9 17.2 12.4 16.5 4.0 29.4
East North Central 14.8 18.2 18.9 5.5 9.0 6.0 12.7
West North Central 7.4 7.0 4.1 1.1 2.2 10.5 3.2
South Atlantic 20.2 19.3 32.7 12.5 8.9 9.0 14.1
East South Central 3.8 6.3 3.4 0.7 1.4 0.7 1.0
West South Central 15.0 13.2 13.2 23.9 7.8 22.2 17.7
Mountain 6.7 7.1 2.0 9.4 6.3 29.5 5.7
Pacific 1.3 10.7 6.1 31.0 43.7 17.7 12.2
Insurance statusf, col %
No insurance 4.3 3.9 4.4 5.5 3.7 4.9 5.1
Private insurance 39.3 51.1 23.3 23.1 50.2 21.8 36.1
Medicaid 51.3 39.5 67.6 66.6 40.9 63.7 52.6
Other 5.1 5.3 4.4 4.7 4.9 8.7 5.8
Urbanizationg, col %
Central metropolitan counties with ≥ 1
million population
31.1 18.3 45.1 49.0 46.1 12.0 43.9
Fringe metropolitan counties with ≥ 1
million population
22.1 25.4 20.4 15.5 22.3 9.4 23.4
Metropolitan counties with
250,000–999,999 population
20.4 21.7 17.7 21.4 19.5 19.0 15.4
Metropolitan counties with
50,000–249,999 population
9.4 11.5 7.5 6.6 4.0 14.3 7.0
Micropolitan counties 10.3 13.9 6.1 5.0 6.5 20.2 6.1
Rural counties 6.4 9.0 3.0 2.0 1.0 25.0 3.2
a A total of 128,742 patients missing data on race/ethnicity (unweighted)
b A total of 138 patients missing data on gender (unweighted)
c A total of 6,304 patients missing data on age (unweighted)
d Chronic conditions defined by the chronic condition indicator of HCUP (Hospital Care and Utilization Program). Examples of included chronic
conditions that may influence AKI include chronic kidney disease, diabetes mellitus, diabetes insipidus, developmental delays, inflammatory bowel
disease, cystic fibrosis, congenital heart disease, and cancer
e Hospital size category is determined based on a combination of location, teaching status, and region
f A total of 4,274 patients missing data on health insurance status (unweighted)
g A total of 6,561 patients missing data on household urbanization (unweighted)
Chronic kidney disease sub-group
If we limited our analyses to only the sub-group of children
diagnosed with CKD (n = 7280, 0.3% of our cohort, weight-
ed), then one-third of those hospitalizations had an episode of
AKI (n = 2401 weighted). This means that AKI amongst kids
with CKD made up 8.2% of the total AKI episodes in this
cohort. Also, the AKI risks amongst males and those without
insurance greatly increased amongst children with CKD
(Supplementary Table 2). For example, amongst children with
CKD, those without insurance have almost 300 more episodes
of AKI per 1000 hospitalizations compared to those with
Medicaid (RD 298.3/1000 hospitalizations, 95% CI 227.1–
369.4, p value < 0.0001). However, the racial disparities disap-
peared, and there were no significant differences in AKI risk
between any racial minority and Caucasian children with CKD.
Table 2 Univariate risk estimates for sociodemographic differences in pediatric AKI episodes
% of all
hospitalizations




95% CI P value
n = 2,392,031 n = 29,391
Race/ethnicitya
Caucasian 46.3 47.6 12.6 Reference
African-American 18.0 19.6 13.4 0.7 − 0.1, 1.5
Hispanic 20.4 16.6 10.0 − 2.7 − 3.6,
− 1.7
< 0.0001
Asian/Pacific Islander 2.1 2.6 14.9 2.2 0.4, 4.1 < 0.01
Native American 0.9 0.8 10.9 − 1.8 − 4.6, 1.1
Other 4.7 4.5 11.6 − 1.0 − 2.4, 0.3
Insurance statusb
Medicaid 51.2 40.4 9.7 Reference
No insurance 4.3 8.1 23.1 13.4 11.7, 15.1 < 0.0001
Private insurance 39.2 43.6 13.7 4.0 3.4, 4.6 < 0.0001
Other 5.1 7.8 18.6 8.9 6.9, 11.0 < 0.0001
Genderc
Female 59.1 43 8.9 Reference
Male 40.9 57 17.1 8.2 7.6, 8.8 < .0001
Aged
1–5 years 22.9 12.3 6.6 Reference
6–10 years 12.7 10.7 10.3 3.7 3.1, 4.4 < 0.0001
11–15 years 17.0 16 11.6 5.0 4.2, 5.8 < 0.0001
16–20 years 47.0 59.9 15.6 9.0 8.4, 9.7 < 0.0001
Household urbanizatione
Central metropolitan counties with ≥ 1 million
population
31.2 30.2 11.9 Reference
Fringe metropolitan counties with ≥ 1 million
population
22.2 23.1 12.9 0.9 0, 1.9 0.05
Metropolitan counties with 250,000–999,999
population
20.5 21.3 12.8 0.9 − 0.3, 2.0
Metropolitan counties with 50,000–249,999
population
9.5 9.4 12.3 0.4 − 0.9, 1.6
Micropolitan counties 10.3 9.7 11.6 − 0.3 − 1.4, 0.7
Rural (neither metro- or micropolitan) counties 6.4 5.7 10.9 − 1.0 − 2.2, 0.1
All risks and risk differences are per 1000 hospitalizations
AKI acute kidney injury, RD risk difference, CI confidence interval
a A total of 128,742 patients missing data on race/ethnicity (unweighted)
b A total of 4,274 patients missing data on health insurance status (unweighted)
c A total of 138 patients missing data on gender (unweighted)
d A total of 6,304 patients missing data on age (unweighted)
e A total of 6,561 patients missing data on household urbanization (unweighted)
Table 3 Multivariate modeling
by sequential addition of potential
confounders
Race + chronic Race + chronic + age +
urban
Race + chronic + age + urban +
insurance + gender
Health insurance
Medicaid Reference Reference Reference
No insurance 14.4 (12.7,
16.2)****
12.9 (11.3, 14.6)**** 11.8 (10.2, 13.4)****
Private insurance 3.4 (2.8,
4.0)****
3.4 (2.9, 4.0)**** 2.8 (2.3, 3.4)****
Other 6.7 (4.8,
8.5)****
6.4 (4.5, 8.3)**** 5.7 (3.8, 7.6)****
Gender
Female – Reference Reference
Male – 7.3 (6.7, 7.9)**** 6.8 (6.2, 7.4)****
Race/ethnicity
Caucasian – – Reference
African-American – – 2.5 (1.7, 3.3)****
Hispanic – – 1.7 (0.9, 2.5)****
Asian/Pacific
Islander
– – 4.5 (2.9, 6.0)****
Native American – – 0.7 (− 2.1, 3.5)
Other – – 1.4 (0.3, 2.5)*
Risk differences per 1000 hospitalizations presented with 95% confidence intervals in parentheses
Race=race/ethnicity; Chronic=chronic illnesses; Age=age in years; Urban=household urbanization
Italics indicates ideal set of confounders to evaluate according to DAG depicted in Fig. 1. Additional confounders
are shown for comparison but may potentially introduce additional bias

































* p-value < 0.01
** p-value < 0.001
*** p-value < 0.0001
***
*
Fig. 2 Risk of AKI by race and chronic illnesses. Error bars represent 95% confidence intervals
Discussion
This is the first large, nationally representative pediatric kid-
ney study to show that lack of health insurance is a risk factor
for poor kidney outcomes. Only slight racial differences
existed for AKI. Chronic illnesses, particularly CKD, also
were associated with pediatric AKI, and they attenuated the
racial disparities. Male gender was a risk factor for increased
risk of pediatric AKI, and the increased risk in males was
highest amongst racial minorities and uninsured children.
Health insurance status
Medicaid was the sociodemographic factor most protective
against AKI. Compared to uninsured children, if a hospitalized
child had Medicaid, his/her absolute risk of being diagnosed
with AKI decreased by 14 per 1000 hospitalizations, control-
ling for comorbidities and race. Translating this to a number
needed to treat approach, this would require 70 uninsured, hos-
pitalized children (95% CI 62–79) to receive Medicaid to po-
tentially prevent one AKI episode. These results should be
interpreted with caution. We cannot account for all unmeasured
confounding in this observational study, and we are limited by
administrative data. Therefore, we cannot conclude a causal
relationship between insurance and AKI. However, our results
are consistent with other studies that have found poor health
outcomes amongst uninsured pediatric patients [21].
In hospitalized children at risk for AKI, health insurance
status may very well be a proxy for further upstream factors
related to access to healthcare. We were limited in our ability
to assess additional indicators for social determinants of health
at the individual level (e.g., income, parents’ level of educa-
tion) or neighborhood level (e.g., percent in poverty, employ-
ment rates, percent with high school diploma). We found that
household urbanization did not affect one’s AKI risk yet one’s
health insurance status did. So perhaps, we are seeing that our
medical system is able to reach the poorest or most remote
neighborhoods, yet the more important sociodemographic
factor to prevent AKI is one’s individual ability and ease to
gain access to our medical system, both preventative and
emergency services because of one’s individual healthcare
insurance status. Out-of-pocket expenses can be a driving
-15 -10 -5 0 5 10 15 20 25 30 35 40






























Fig. 3 Risk differences of AKI for those with no health insurance versus those with Medicaid, adjusted for chronic illnesses and stratified by race and
gender. Error bars represent 95% confidence intervals
force for healthcare seeking behaviors. Therefore, this also
seems congruent with our findings that both uninsured and
those with private insurance had higher risks of AKI than
those withMedicaid. Patients with private insurancemay have
high co-pays, different levels of coverage depending on their
insurer, and may fluctuate in and out of insurance depending
on parental job stability, while those with Medicaid have little
to no co-pays and more stability on the insurance plan.
Health insurance status is unique in the pediatric population
and is considered a social determinant of health by the Healthy
People 2020 initiative [22]. In all states, many children who
are not eligible for private insurance are eligible for some form
of government-assisted insurance, such as Medicaid [23–25].
Pediatric patients who have no insurance are a unique group of
patients, typically due to health literacy barriers, eligibility
issues such as citizenship status, or family preference to de-
cline coverage. If our results are confirmed in future research
studies that include granular data beyond the limited adminis-
trative data in this database, then perhaps interventions should
evaluate ways to improve access to healthcare insurance to all
children at risk of AKI.
The only other pediatric kidney study to look at social
determinants of health focused on parental, self-reported in-
come level in children with chronic kidney disease, and they
found no difference in the rate of kidney disease based on
income [26]. However, that study was limited by its smaller
size (n = 572) and inclusion only of children actively involved
in medical care, creating a selection bias against those with
poor access to care and without insurance. Future pediatric
nephrology studies are needed to assess disparities in social
determinants of health, not just in those at risk for AKI.
A unique feature of AKI risk amongst patients uninsured in
our cohort is that it seems to be worst amongst the 19- and 20-
year-olds. This may be a true risk or a glimpse at the under-
diagnosis of AKI in younger children. Nineteen- and twenty-
year-old patients may be a high-risk population that are no
longer eligible for most state Medicaid programs (47% of
uninsured patients are 19–20 years of age). However, older
pediatric patients have greater muscle mass and hence higher
baseline creatinine levels making them more akin to adult
levels, which may allow easier recognition and subsequently
improved coding of AKI amongst older children. This was
also seen as gender AKI risks were attenuated when we re-
moved 19- and 20-year-olds from the analysis.
Race/ethnicity
Disparities amongst populations with lower socioeconomic
status (SES) and racial minorities often are intertwined due
to their co-existence. Just as lower SES groups are more likely
to experience poorer health outcomes, minority groups have
been more likely to report poorer health status compared to
Caucasians [9, 10, 27]. As an example, a recent study on
appendiceal ruptures saw improvements in all racial groups
after insurance coverage increased, but more pronounced im-
provements amongst minorities [28].
Though the differences are small, our finding of increased
AKI risk in minority groups is of significance given the large
number of hospitalized pediatric patients at risk of AKI annu-
ally in the USA. This analysis of a large, nationally represen-
tative cohort allowed us to see these small differences that
may be missed in smaller studies. These risks are not
completely attenuated after stratifying by insurance status
and controlling for comorbidities. Asian/Pacific Islander,
African-American, and Hispanic children have a slightly
higher risk of AKI compared to Caucasian children.
Part of the racial differences seen in this study may be
due to differing levels of medical care in hospitals pre-
dominantly caring for minority groups or other SES fac-
tors we were unable to capture in this analysis. Chronic
conditions alone are also a major risk factor for AKI, and
they attenuated much of the racial disparities seen in this
study, suggesting the possibility of a genetic component
or other uncaptured confounder of the association be-
tween race and AKI. Risk variants of the apolipoprotein
L1 (APOL1) gene have been consistently cited to explain
much of the racial burden of chronic kidney disease as
APOL1 is more prevalent in African-Americans, but this
has not been consistently shown in AKI literature
[29–33]. A large adult cohort study did not find evidence
that APOL1 risk variants had a higher risk of AKI com-
pared to those without these variants; though this evalua-
tion assessed APOL1 risk variants found in chronic renal
conditions [34]. A large genome-wide association study in
AKI found two distinct genetic loci (single-nucleotide
polymorphisms) on chromosome 4 nearby yet distinct
from the APOL1-regulator, IRF2, which has been associ-
ated with the high risk of chronic kidney failure in
African-Americans [35].
Further research is needed to evaluate the higher AKI inci-
dence in Asian/Pacific Islander children as this has not been
seen in other studies. However, other studies often focus only
on Caucasian, African-American, and/or Hispanic sub-
groups, excluding Asian and Pacific Islander children due to
sample size issues. It is known in adults that people from the
Pacific Islands have higher rates of chronic renal failure than
any other racial or ethnic group [36]. This cohort did not allow
for further refinement as children were a priori grouped to-
gether as “Asian/Pacific Islander.”
Gender
Our study also found a higher AKI risk amongst male
patients when compared with females, after controlling
for comorbidities, race/ethnicity, age, and household ur-
banization (Fig. 4). While adult AKI studies also show
males to be at increased risk [37], this is often explained by
the gender differences in undiagnosed comorbid conditions
(e.g., hypertension, hyperglycemia), which are less com-
mon in the pediatric population. The gender differences
in pediatric AKI risk may be related to underlying disease
rate differences in congenital conditions, such as congeni-
tal anomalies of the kidney and urinary tract, which are
more common in boys. There also may be a differential
bias in detection of AKI, perhaps due to differing muscle
mass in the adolescent population.
Age
The higher AKI risk found in older children in this study
should be viewed with caution as the outcomes of AKI are
from administrative data only. There may be a true increasing
risk of AKI with increasing age, but our study may also be
highlighting the lack of recognition of AKI in younger chil-
dren and not a true increased risk. Younger children with low
baseline creatinine levels (e.g., 0.2–0.4 mg/dL) may have a
significant AKI with doubling of their creatinine and still
remain with creatinine levels ≤ 1 mg/dL (normal for an adult),
an easy miss for providers less familiar with pediatric varia-
tions in creatinine levels.
Limitations
This study is a secondary analysis of voluntary, administrative
data submitted by hospitals to a national database. Hospitals
can choose whether to participate, which may potentially in-
troduce bias to the available data. The unit of measurement is a
hospitalization, so recurrent AKI episodes in one individual in
separate hospitalizations is possible. We are unable to link
individuals and consequently cannot account for potential re-
peat outcomes. Our primary outcome (AKI) relies solely on
appropriate recognition and ICD coding, which has been
shown to be flawed with significant underreporting, in partic-
ular for AKI [38–41]. Hence, it is likely that our AKI estimates
under-report the true incidence of disease and perhaps the
disparities that exist. This also likely explains the discrepancy
between our national incidence of AKI (1.2%) being much
below other reports of about 5%.
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Fig. 4 Risk differences of AKI for males versus females, adjusted for chronic illnesses and stratified by health insurance status and race/ethnicity. Error
bars represent 95% confidence intervals
We attempted to evaluate both an individual social deter-
minant of health and a neighborhood-level factor. In assessing
these variables, we consider both the individual’s access to
medical care as well as geographic barriers to care. This anal-
ysis was limited by the available indicators for social determi-
nants of health in the KID. Evaluating other factors, such as
citizenship status, census tract income level, and parental ed-
ucation level, may provide a clearer understanding of the
higher risk of AKI amongst lower-resourced or lower SES
populations as seen in this study.
However, this study also has important strengths. By ana-
lyzing such a large national database with a diverse patient
population that represents almost every state in the country,
we can provide an overview of the AKI burden and associated
disparities at a national level that would not otherwise be
apparent. Specifically, we included a large proportion of mi-
norities who are often not represented in kidney research
(Hispanics, Asian/Pacific Islanders, and uninsured popula-
tions). Unlike other research on insurance disparities, we are
able to distinguishMedicaid from no insurance, highlighting a
distinct risk difference associated with AKI risk in these two
different populations. This study was not designed to evaluate
AKI risks amongst children with CKD specifically, but it cer-
tainly deserves further exploration as there was quite a high
incidence of AKI amongst children with CKD (33%).
Conclusions
Pediatric AKI occurs in 12 of every 1000 pediatric hospitaliza-
tions. In the largest, nationally representative cohort, the biggest
protective factor against developing AKI is a child having health
insurance. Our research should be confirmed with data sources
other than administrative data as we are limited by what is accu-
rately coded. Potential improved data sources would be prospec-
tive cohorts or network collaborations amongst hospitals that
provide laboratory data to more accurately capture all AKI epi-
sodes. However, our data suggest that we could potentially pre-
vent 1 episode of AKI for every 70 uninsured hospitalized chil-
dren provided with Medicaid. Our study showed that racial dis-
parities exist amongst those with pediatric AKI. Though these
risks are greatly attenuated by chronic conditions, racial minori-
ties had higher risks compared to Caucasians. Also, hospitalized
boys were at an increased risk of AKI compared to girls, con-
trolling for comorbidities, race, age, and household urbanization.
More granular data is needed to explore the sociodemographic
disparities seen in this large cohort. We need to evaluate if these
disparities persist when we can evaluate all episodes of AKI and
not just those recognized and subsequently coded by clinicians as
these are just the tip of the iceberg.
If these disparities are confirmed, this is concerning as this
may be contributing to disparities seen later in life with adult
disparities in CKD. Expanding health insurance coverage to
children currently uninsured should be explored further as a
potential preventative approach for pediatric AKI, particularly
amongst potentially high-risk populations 19- and 20-year-
olds and those with CKD.
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